The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our unaudited financial statements
and related notes appearing elsewhere in this quarterly report. In addition to
historical financial information, the following discussion includes certain
forward-looking statements that reflect our plans, estimates and our current
views with respect to future events and financial performance. Forward-looking
statements are often identified by words like: believe, expect, estimate,
anticipate, intend, project and similar expressions, or words which, by their
nature, refer to future events. You should not place undue certainty on these
forward-looking statements, which apply only as of the date of this report.
Except as required by applicable law, including the securities laws of the
United States, we do not intend to update any of the forward-looking statements
to conform these statements to actual results.



New Business



On December 28, 2021, we entered into an asset purchase agreement (the "Purchase
Agreement") with Sapir Pharmaceuticals, Inc., a Delaware corporation ("Sapir"),
pursuant to which we purchased certain assets from Sapir used in connection with
the proprietary stabilized formulation of the Epigallocatechin-gallate (EGCG)
molecule (the "Business") in exchange for 1,000,000 shares of newly-designated
Series A preferred stock (the "Preferred Stock"). The closing of the acquisition
occurred simultaneous with the execution and delivery of the Purchase Agreement.



At the closing, the parties also executed and delivered a royalty agreement (the
"Royalty Agreement") pursuant to which we agreed to pay Sapir a royalty equal to
5% of the gross revenues realized from licenses or products generated or derived
from the Business.



Due to circumstances beyond the control of the parties, we were unable to
develop the Business to the extent contemplated by (i) the Purchase Agreement
and the Royalty Agreement (together, the "Sapir Agreements") and (ii)
discussions that occurred between us and Sapir following the closing of the
Purchase Agreement. As a result, on June 6, 2022, we entered into a rescission
agreement with Sapir (the "Rescission Agreement") in order to rescind the
Purchase Agreement and the Royalty Agreement and restore both us and Sapir to
the respective positions we occupied immediately in advance of the execution and
delivery of the Sapir Agreements.



As of the date of the Rescission Agreement, we had not completed the issuance of the Preferred Stock to Sapir or completed any payments to Sapir under the Royalty Agreement.





In connection with the Sapir transaction, on January 14, 2022, we entered into a
settlement and termination agreement (the "Settlement Agreement") with Lode Star
Gold, Inc., a private Nevada corporation and our former controlling shareholder
("LSG"), in order to terminate the mineral option agreement between the parties
dated October 4, 2014, as amended on October 31, 2019 (together, the "Option
Agreement"). The Settlement Agreement provided for the immediate termination of
the Option Agreement (with the exception of certain standard provisions that
survived according to their terms); the forgiveness by LSG of all amounts owing
by us to LSG thereunder, which includes approximately $2.224 million in accrued,
unpaid penalty and other payments (collectively, the "Debt"); and the return to
LSG of our 20% undivided interest in and to the mineral property that was the
subject of the Option Agreement.



On June 8, 2022, and in connection with the rescission of the Sapir Agreements,
we entered into a debt reinstatement agreement (the "Reinstatement Agreement")
with LSG pursuant to which we agreed to reinstate the Debt. Also on June 8,
2022, we entered into debt conversion agreements with three related parties,
including LSG, pursuant to which the creditors converted an aggregate of
$2,601,207 in accrued, unpaid debt into 70,302,906 shares of our common stock at
a price of $0.037 per share.



At present, the Company has no has no current business project and is actively seeking business opportunities.





Funding


At present, we have no sustainable financing in place other than remedial expenses still being advanced by LSG.





Personnel


We have no employees. Our President and CEO, Mark Walmesley, receives no compensation for his services. We expect to continue to use outside consultants, advisors, attorneys and accountants as necessary.





Our former CFO and Corporate Secretary, Samuel Sternheim, resigned effective
September 6, 2022. Mark Walmesley has taken over his role as CFO, Secretary and
Treasurer.

                                       12



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS (Continued)




Going Concern



There is substantial doubt that we can continue as an on-going business for the
next twelve months unless we obtain additional capital to pay our expenses. This
is because we have not generated any revenues to-date and we cannot currently
estimate the timing of any possible future revenues. Our only source of cash at
this time is from loans.



Results of Operations



The following summary of our results of operations should be read in conjunction
with our financial statements for the period ended September 30, 2022 which are
included above in Part I, Item 1.



                                               Three Months Ended September 30                    Change
                                                 2022                   2021              Amount         Percentage
                                                   $                      $                  $
Revenue                                                    -                     -                -               -
Operating Expenses                                    10,505                76,548          (66,043 )         (86%)
Operating Loss                                       (10,505 )             (76,548 )        (66,043 )         (86%)
Other Income (Expense)                                (1,664 )            

(25,341 )        (23,677 )         (93%)
                                                     (12,169 )            (101,889 )        (89,720 )         (88%)

                                               Nine Months Ended September 30                     Change
                                                 2022                   2021              Amount         Percentage
                                                   $                      $                  $
Revenue                                                    -                     -                -               -
Operating Expenses                                   143,398               263,466          120,068           (45%)
Operating Loss                                      (143,398 )            (263,466 )       (120,068 )         (45%)
Other Income (Expense)                             2,184,446              

(72,348 )      2,256,794           3019%
                                                   2,041,048              (355,814 )      2,396,862            674%




Revenues



We had no operating revenues during the three month and nine month periods ended
September 30, 2022 and 2021. We had a net loss of $12,169 during the current
quarter and recorded net income of $2,041,048 for the nine month period ended
September 30, 2022, which was entirely attributable to the rescission of the
Sapir transaction as described above.



Expenses


Notable year over year differences in expenses for the third quarter in 2022 compared to 2021 are as follows:





                                             Nine Months Ended September 30               Increase/(Decrease)
                                               2022                  2021               Amount          Percentage
                                                 $                     $                  $
Consulting services                                58,321                93,883           (35,562 )             (38 %)
Exploration and evaluation                              -                28,443           (28,443 )            (100 %)
Mineral option fees                                     -                75,000           (75,000 )            (100 %)
Professional fees                                  52,719                35,715            17,004                48 %
Interest, bank and finance charges                  2,471                72,348           (69,877 )             (97 %)




Consulting fees decreased during the nine month period ended September 30, 2022
as Mark Walmesley no longer provided strategic consulting services during the
three months ended September 30, 2022 ($25,000 per quarter in previous
quarters).



Exploration and evaluation expense and mineral option fees were reduced to $Nil
in the nine month period ended September 30, 2022 due to the Company terminating
its mineral property option and no longer spending on mining efforts.

                                       13



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS


        OF OPERATIONS (Continued)




Interest, bank and finance charges in the nine month period ended September 30,
2022 decreased as the Company settled various interest bearing loans during

the
period.



Professional fees in the nine month period ended September 30, 2022 included
legal, audit and bookkeeping were increased as the Company paid its OTC Markets
annual fee and continued to restructure itself following the rescinding of

the
Sapir transaction.


Liquidity and Capital Resources


At September 30, 2022, the Company's total assets were $4,484 and its total
liabilities were $20,878. The Company's working capital deficiency at September
30, 2022 was $16,394. For December 31, 2021 the Company had a working capital
deficiency of $225,586. The Company has no current business project and no cash
generating operations. Management is actively seeking business opportunities.
Our primary source of funding is from loans advanced to us from our largest
shareholder, LSG, and other related parties.



Cash Flows



                                         Nine Months Ended September 30                Increase/(Decrease)
                                           2022                  2021               Amount           Percentage
                                             $                     $                  $
Cash Flows Provided By (Used In):
Operating Activities                          (61,112 )             (56,353 )          (4,759 )               (8 %)
Financing Activities                           59,315                55,000             4,315                  8 %
Net increase (decrease) in cash                (1,797 )              (1,353

)            (444 )              (33 %)




We have yet to generate any revenues from our business operation and our ability
to generate adequate amounts of cash to meet our needs is entirely dependent on
the issuance of shares or loans, which have been our principal sources of
working capital so far. For the foreseeable future, we will have to continue to
rely on those sources for funding. We have no assurance that we can successfully
engage in any further private sales of our securities or that we can obtain any
additional loans.

© Edgar Online, source Glimpses